Topic
Advances in CF Treatment: Have We Achieved a New Norm?

Introduction By
Daniel V. Schidlow, MD, Dean Emeritus Professor of Pediatrics, Medicine Pharmacology and Physiology

Presented By
Stanley B. Fiel, MD, Professor of Medicine, Sidney Kimmel Medical College at Thomas Jefferson University; regional chairman, Department of Medicine/Atlantic Health System; The deNeufville Professor and Chairman Department of Medicine, Morristown Medical Center

Learning Objectives

• Discuss how has targeted therapy in Cystic Fibrosis come to get us closer to a “cure”
• Define the mechanism of Action (MOA) of cystic fibrosis transmembrane conductance regulator (CFTR) modulators
• Understand how CFTR modulators are changing the future of Cystic Fibrosis care

Target Audience
Physicians, nurse practitioners, nursing personnel, fellows, residents, medical students and other health care professionals who take care of children

Accreditation Statement
Tower Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.

Tower Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Claiming CME Credits
Attendees MUST sign in with the six-digit activity code provided at the session using eeds within 24 hours of the conference start time and complete the online evaluation within 30 days at